CBPO - チャイナ・バイオロジック・プロダクツ (China Biologic Products Holdings Inc.) チャイナ・バイオロジック・プロダクツ

 CBPOのチャート


 CBPOの企業情報

symbol CBPO
会社名 China Biologic Products Inc (チャイナ・バイオロジック・プロダクツ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 チャイナ・バイオロジック・プロダクツ・ホールディングス(China Biologic Products Holdings Inc.)はバイオ製薬会社である。同社は中国においてヒト血漿ベースのバイオ医薬品の研究・開発・製造・販売に従事する。同社はヒト血漿製品の製造と販売を通じて事業を運営する。同社は20種類以上の血漿製品及び9種類の他のバイオ医薬品製剤を含む製品ポートフォリオを有する。同社の製品にはヒト・アルブミン、ヒト免疫グロブリン、静脈注射用免疫グロブリン(IVIG)、ヒトB型肝炎免疫グロブリン、ヒト狂犬病免疫グロブリン、ヒト破傷風免疫グロブリン、胎盤ポリペプチド、第VIII因子及びヒト・プロトロンビン複合体濃縮物(PCC)を含む。   チャイナ・バイオロジック・プロダクツは、中国のバイオ医薬品企業。ヒト血漿ベ―スの医薬品を開発、製造、販売を中国で従事する。主要製品は、ヒトアルブミンおよび免疫グロブリン製品。ドナ―から血漿を収集するプラズマステ―ションを所有・運営する。直接病院や接種センタ―に、または中国での代理店を通じて製品を販売する。   
本社所在地 18th Floor Jialong International Building 19 Chaoyang Park Road Chaoyang District Beijing 100125 CHN
代表者氏名
代表者役職名
電話番号 +86 10-6598-3111
設立年月日 32843
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 1799人
url www.chinabiologic.com
nasdaq_url https://www.nasdaq.com/symbol/cbpo
adr_tso
EBITDA EBITDA(百万ドル) ー
終値(lastsale) 77.86
時価総額(marketcap) 2605607557.26
時価総額 時価総額(百万ドル) 2645.836
売上高 売上高(百万ドル) --
企業価値(EV) 企業価値(EV)(百万ドル) 2279.6627
当期純利益 当期純利益(百万ドル) --
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 China Biologic Products Holdings Inc revenues increased 29% to $232.8M. Net income applicable to common stockholders increased 2% to $60.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling expenses increase from $7.4M to $45M (expense).

 CBPOのテクニカル分析


 CBPOのニュース

   The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout  2021/02/18 13:14:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Advaxis, Inc. (NASDAQ: ADXS ) Angion Biomedica Corp (NASDAQ: ANGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avanos Medical Inc (NYSE: AVNS ) Bausch Health Companies Inc (NYSE: BHC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bioatla Inc (NASDAQ: BCAB ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Chimerix Inc (NASDAQ: CMRX ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Endo International PLC (NASDAQ: ENDP ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Lucira Health Inc (NASDAQ: LHDX ) Nektar Therapeutics (NASDAQ: NKTR ) (announced a $150-million investment by SFJ Pharma for the Phase 2/3 registrational clinical study of BEMPEG plus Keytruda in patients with head and neck cancer) Oncolytics Biotech, Inc. (NASDAQ: ONCY ) (reacted to initiation of coverage by H.C.
   China Biologic Products Must-See Earnings Estimates for: Stock market Insights & financial analysis  2020/11/24 15:50:00 Stock Market Daily
China Biologic Products announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   China Biologic Products Will stock surge before Earnings results? Stock market Insights & financial analysis  2020/11/11 12:50:00 Stock Market Daily
China Biologic Products announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Global Plasma Protein Therapeutics Market Growth, Trends, and Forecasts 2020-2025: Key Players are Takeda Pharma, Octapharma, Grifols, CSL Behring, Biotest, Baxter, and China Biologic Products - ResearchAndMarkets.com  2020/10/27 12:43:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Plasma Protein Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The plasma protein therapeutics market studied has been projected to grow with a CAGR of nearly 5.3% over the forecast period The major factor attributing to the growth of the market is increasing prevalence of immune deficiency disorders, autoimmune disorders, neurological and bleeding disorders. In addition, the rise in ger
   China Biologic Products (NASDAQ:CBPO) Rating Increased to Hold at BidaskClub  2020/10/22 06:56:47 Dakota Financial News
China Biologic Products (NASDAQ:CBPO) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Tuesday, BidAskClub reports. Separately, Zacks Investment Research downgraded China Biologic Products from a “buy” rating to a “hold” rating in a research report on Monday, June 22nd. Shares of […]
   The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout  2021/02/18 13:14:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Advaxis, Inc. (NASDAQ: ADXS ) Angion Biomedica Corp (NASDAQ: ANGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avanos Medical Inc (NYSE: AVNS ) Bausch Health Companies Inc (NYSE: BHC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bioatla Inc (NASDAQ: BCAB ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Chimerix Inc (NASDAQ: CMRX ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Endo International PLC (NASDAQ: ENDP ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Lucira Health Inc (NASDAQ: LHDX ) Nektar Therapeutics (NASDAQ: NKTR ) (announced a $150-million investment by SFJ Pharma for the Phase 2/3 registrational clinical study of BEMPEG plus Keytruda in patients with head and neck cancer) Oncolytics Biotech, Inc. (NASDAQ: ONCY ) (reacted to initiation of coverage by H.C.
   China Biologic Products Must-See Earnings Estimates for: Stock market Insights & financial analysis  2020/11/24 15:50:00 Stock Market Daily
China Biologic Products announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   China Biologic Products Will stock surge before Earnings results? Stock market Insights & financial analysis  2020/11/11 12:50:00 Stock Market Daily
China Biologic Products announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Global Plasma Protein Therapeutics Market Growth, Trends, and Forecasts 2020-2025: Key Players are Takeda Pharma, Octapharma, Grifols, CSL Behring, Biotest, Baxter, and China Biologic Products - ResearchAndMarkets.com  2020/10/27 12:43:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Plasma Protein Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The plasma protein therapeutics market studied has been projected to grow with a CAGR of nearly 5.3% over the forecast period The major factor attributing to the growth of the market is increasing prevalence of immune deficiency disorders, autoimmune disorders, neurological and bleeding disorders. In addition, the rise in ger
   China Biologic Products (NASDAQ:CBPO) Rating Increased to Hold at BidaskClub  2020/10/22 06:56:47 Dakota Financial News
China Biologic Products (NASDAQ:CBPO) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Tuesday, BidAskClub reports. Separately, Zacks Investment Research downgraded China Biologic Products from a “buy” rating to a “hold” rating in a research report on Monday, June 22nd. Shares of […]

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 チャイナ・バイオロジック・プロダクツ CBPO China Biologic Products Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)